Australia's most trusted
source of pharma news
Saturday, 12 July 2025
">
Posted 8 July 2024 PM
Powerful lobby groups in Washington are urging US President Donald Trump to retaliate against Australian "freeloading" with the pharma industry clearly in the firing line.
The US Chamber of Commerce and the National Taxpayers Union have joined PhRMA in urging the White House to push back against countries that use pricing policies to undervalue American innovation, with specific reference to the pharma industry.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.